SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-156534
Filing Date
2021-05-11
Accepted
2021-05-10 19:13:27
Documents
102
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d143487d10q.htm 10-Q 559312
2 EX-10.2 d143487dex102.htm EX-10.2 67804
3 EX-10.3 d143487dex103.htm EX-10.3 68469
4 EX-10.4 d143487dex104.htm EX-10.4 15689
5 EX-31.1 d143487dex311.htm EX-31.1 7343
6 EX-31.2 d143487dex312.htm EX-31.2 7334
7 EX-32.1 d143487dex321.htm EX-32.1 4902
  Complete submission text file 0001193125-21-156534.txt   5980113

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT orgo-20210331.xml EX-101.INS 1115088
9 XBRL TAXONOMY EXTENSION SCHEMA orgo-20210331.xsd EX-101.SCH 63815
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orgo-20210331_cal.xml EX-101.CAL 64993
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20210331_def.xml EX-101.DEF 387628
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20210331_lab.xml EX-101.LAB 536067
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20210331_pre.xml EX-101.PRE 505847
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 21909062
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences